Robert Mittendorff

Robert Mittendorff, MD, MBA, currently serves as a General Partner and Head of Healthcare at B Capital Group since March 2021. In addition to this role, Robert holds multiple board positions including Board Member at Nalu Medical, Inc. and CARRICK THERAPEUTICS UK LIMITED, and Member of the Board of Directors at Capital Rx, Carlsmed, Lively, Inc., and HotSpot Therapeutics, Inc. Other notable roles include Board Member at Triumvira Immunologics, Inc., Board Observer at Aetion and Volastra Therapeutics. Robert's educational background includes an MBA from Harvard Business School, an MD from Harvard Medical School, and a Master's in International Affairs from King's College London, along with a B.S. in Biomedical/Electrical Engineering from The Johns Hopkins University. Additionally, Robert completed a residency in Emergency Medicine at Stanford University School of Medicine and pursued graduate studies in Systems Engineering/Financial Engineering at the Massachusetts Institute of Technology.